Mirum Pharmaceuticals Inc (MIRM)
24.78
-0.21
(-0.84%)
USD |
NASDAQ |
May 16, 16:00
24.78
0.00 (0.00%)
After-Hours: 20:00
Mirum Pharmaceuticals Price to Book Value: 4.978 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 15, 2024 | 5.021 |
| May 14, 2024 | 4.982 |
| May 13, 2024 | 4.978 |
| May 10, 2024 | 4.974 |
| May 09, 2024 | 5.189 |
| May 08, 2024 | 5.031 |
| May 07, 2024 | 5.206 |
| May 06, 2024 | 5.302 |
| May 03, 2024 | 5.191 |
| May 02, 2024 | 5.142 |
| May 01, 2024 | 5.166 |
| April 30, 2024 | 5.043 |
| April 29, 2024 | 5.035 |
| April 26, 2024 | 4.913 |
| April 25, 2024 | 4.919 |
| April 24, 2024 | 4.824 |
| April 23, 2024 | 4.905 |
| April 22, 2024 | 4.854 |
| April 19, 2024 | 4.782 |
| April 18, 2024 | 4.734 |
| April 17, 2024 | 4.790 |
| April 16, 2024 | 4.822 |
| April 15, 2024 | 4.802 |
| April 12, 2024 | 4.937 |
| April 11, 2024 | 5.188 |
| Date | Value |
|---|---|
| April 10, 2024 | 5.148 |
| April 09, 2024 | 5.256 |
| April 08, 2024 | 5.200 |
| April 05, 2024 | 5.268 |
| April 04, 2024 | 5.081 |
| April 03, 2024 | 4.963 |
| April 02, 2024 | 5.057 |
| April 01, 2024 | 5.105 |
| March 31, 2024 | |
| March 28, 2024 | 4.748 |
| March 27, 2024 | 4.748 |
| March 26, 2024 | 4.710 |
| March 25, 2024 | 4.941 |
| March 22, 2024 | 4.939 |
| March 21, 2024 | 4.922 |
| March 20, 2024 | 5.102 |
| March 19, 2024 | 5.105 |
| March 18, 2024 | 4.911 |
| March 15, 2024 | 5.06 |
| March 14, 2024 | 5.325 |
| March 13, 2024 | 5.249 |
| March 12, 2024 | 5.194 |
| March 11, 2024 | 5.092 |
| March 08, 2024 | 5.321 |
| March 07, 2024 | 5.330 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.076
Minimum
Nov 20 2019
19.35
Maximum
Sep 15 2023
5.475
Average
4.978
Median
Price to Book Value Benchmarks
| Vanda Pharmaceuticals Inc | 0.5975 |
| Sarepta Therapeutics Inc | 13.05 |
| Puma Biotechnology Inc | 4.168 |
| Reneo Pharmaceuticals Inc | 0.6829 |
| Tharimmune Inc | 0.5977 |
Price to Book Value Related Metrics
| PS Ratio | 4.778 |
| PEG Ratio | -2.114 |
| Price | 24.78 |
| Earnings Yield | -15.17% |
| Market Cap | 1.168B |
| PEGY Ratio | -2.114 |